CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

Genetically edited immune cells can persist, thrive, and function months after a cancer patient receives them.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200206144845.htm